Literature DB >> 23155211

CD14(+)S100A9(+) myeloid-derived suppressor cells portend decreased survival in patients with advanced lung cancer.

Sherven Sharma, Steven Dubinett, Ravi Salgia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23155211      PMCID： PMC4249776          DOI： 10.1164/rccm.201209-1597ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  5 in total

1.  S100A9 a new marker for monocytic human myeloid-derived suppressor cells.

Authors:  Fei Zhao; Bastian Hoechst; Austin Duffy; Jaba Gamrekelashvili; Suzanne Fioravanti; Michael P Manns; Tim F Greten; Firouzeh Korangy
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

2.  Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.

Authors:  Bethany L Mundy-Bosse; Gregory B Lesinski; Alena C Jaime-Ramirez; Kristen Benninger; Mahmood Khan; Periannan Kuppusamy; Kristan Guenterberg; Sri Vidya Kondadasula; Abhik Ray Chaudhury; Krista M La Perle; Melanie Kreiner; Gregory Young; Denis C Guttridge; William E Carson
Journal:  Cancer Res       Date:  2011-06-16       Impact factor: 12.701

3.  COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells.

Authors:  Mitsugu Fujita; Gary Kohanbash; Wendy Fellows-Mayle; Ronald L Hamilton; Yoshihiro Komohara; Stacy A Decker; John R Ohlfest; Hideho Okada
Journal:  Cancer Res       Date:  2011-02-15       Impact factor: 12.701

4.  CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer.

Authors:  Po-Hao Feng; Kang-Yun Lee; Ya-Ling Chang; Yao-Fei Chan; Lu-Wei Kuo; Ting-Yu Lin; Fu-Tsai Chung; Chih-Shi Kuo; Chih-Teng Yu; Shu-Min Lin; Chun-Hua Wang; Chun-Liang Chou; Chien-Da Huang; Han-Pin Kuo
Journal:  Am J Respir Crit Care Med       Date:  2012-09-06       Impact factor: 21.405

5.  Myeloid suppressor cell depletion augments antitumor activity in lung cancer.

Authors:  Minu K Srivastava; Li Zhu; Marni Harris-White; Upendra K Kar; Upendra Kar; Min Huang; Ming F Johnson; Jay M Lee; David Elashoff; Robert Strieter; Steven Dubinett; Sherven Sharma
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240
  5 in total
  2 in total

1.  Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients.

Authors:  Marta Usó; Eloísa Jantus-Lewintre; Silvia Calabuig-Fariñas; Ana Blasco; Eva García Del Olmo; Ricardo Guijarro; Miguel Martorell; Carlos Camps; Rafael Sirera
Journal:  Oncoimmunology       Date:  2016-12-07       Impact factor: 8.110

2.  Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.

Authors:  Sze Wing Wong; Joshua McCarroll; Kenneth Hsu; Carolyn L Geczy; Nicodemus Tedla
Journal:  Front Immunol       Date:  2022-05-17       Impact factor: 8.786
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.